Page 255 - Demo

SECTION I: MOLECULAR GENETIC ENGINEERING AND BIOCHEMICAL TECHNOLOGY 25915. Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus as potential probiotics: Status, concerns, and future perspectives. Front Microbiol 2017, vol. 8, no. AUG, p. 271541.16. Marzorati M, Van den Abbeele P, Bubeck SS, et al. Bacillus subtilis HU58 and Bacillus coagulans SC208 probiotics reduced the effects of antibiotic-induced gut microbiome dysbiosis in an M-SHIME%u00ae Model. Microorganisms 2020, vol. 8, no. 7, p. 1028.17. Calvigioni M, Bertolini A, Codini S, et al. HPLC-MS-MS quantification of short-chain fatty acids actively secreted by probiotic strains. Front Microbiol 2023, vol. 14, p. 1124144.18. Zhu J, Chen Y, Imre K, et al. Mechanisms of probiotic Bacillusagainst enteric bacterial infections. One Health Advances 2023, vol. 1, no. 1, pp. 1%u201322.19. Sun J, Wang F, Hong G, et al. Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress. Neurosci Lett 2016, vol. 618, pp. 159%u2013166.20. Han KM, Ham BJ. How inflammation affects the brain in depression: a review of functional and structural MRI studies. J Clin Neurol 2021, vol. 17, no. 4, p. 503.21. Hasler G. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry 2010, vol. 9, no. 3, p. 15522. Neumeister A, Nugent AC, Waldeck T, et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 2004, vol. 61, no. 8, pp. 765%u2013773.23. LaGreca M, Hutchinson DR, Skehan L. The microbiome and neurotransmitter activity. The Journal of Science and Medicine 2021, vol. 3, no. 2.